Press release
Sarcoma Drug Market Increasing Demand, Growth Analysis and Future Outlook by 2031
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sarcoma-drug-market
Further, in November 2021, Aadi Bioscience's Fyarro, its first commercial product, was approved by the FDA for adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors. The FDA approved Fyarro based on data from a phase 2 registrational trial, with 29.9% of patients achieving an overall response.
Furthermore, in February 2020, Epizyme's Tazverik, a first-in-class EZH2 inhibitor, was approved for treating epithelioid sarcoma (ES), a rare soft tissue tumor. The drug, which is expected to gain market value through wider use in more lucrative cancer settings, is expected to be available in the US for approximately 300 patients.
Global Sarcoma Drug Market Report Segment
By Treatment Type
Chemotherapy
Targeted Therapy
Immunotherapy
Others (Radiation Therapy)
By Disease Indication
Soft Tissue Sarcoma (STS)
Bone Sarcoma
Gastrointestinal Stromal Tumors (GIST)
Kaposi Sarcoma
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
A full report of Sarcoma Drug Market available @ https://www.omrglobal.com/industry-reports/sarcoma-drug-market
Company Profiles
AbbVie Inc.
Adaptimmune Ltd.
Arcus Biosciences, Inc.
AstraZeneca Plc
Bristol Myers Squibb Co.
Eisai Co., Ltd.
Hoffmann-La Roche Ltd.
Fresenius Kabi AG
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Reasons to Buying From us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f
Contact Us:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcoma Drug Market Increasing Demand, Growth Analysis and Future Outlook by 2031 here
News-ID: 3736790 • Views: …
More Releases from Orion Market Research
AI in Oil and Gas Market - Industry Trends and Forecast to 2032
The global Artificial Intelligence (AI) in the oil and gas market was valued at approximately $5.86 billion in 2023 and is projected to reach around $19.36 billion by 2032, growing at a compound annual growth rate (CAGR) of 14.20% from 2024 to 2032.
AI in Oil and Gas Market Overview
The integration of AI in the oil and gas industry is transforming operations by enhancing efficiency, safety, and decision-making processes.…
SuperSpeed USB Controller Market Overview: Growth, Share, Value, Size, and Scope
The global SuperSpeed USB controller market was valued at approximately $8.8 billion in 2023 and is projected to reach around $18.34 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2024 to 2032.
SuperSpeed USB Controller Market Overview
The SuperSpeed USB controller market is experiencing robust growth, driven by the increasing demand for high-speed data transfer in consumer electronics, data centers,…
Fault Passage Indicators Market: An In-Depth Analysis
The global Fault Passage Indicators (FPI) market was valued at approximately $1.5 billion in 2023 and is projected to reach around $2.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2032.
Fault Passage Indicators Market Overview
The Fault Passage Indicators market is experiencing significant growth, driven by the increasing adoption of smart grid technologies and the need to enhance the reliability and…
Remote Terminal Units (RTUs) Market: A Comprehensive Overview
The global Remote Terminal Units (RTUs) market was valued at approximately $3.4 billion in 2023 and is projected to reach around $5.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2032.
Remote Terminal Units (RTUs) Market Overview
The RTUs market is experiencing significant growth, driven by the increasing adoption of automation and remote monitoring across various industries, including oil and gas, power…
More Releases for Sarcoma
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma…
Kaposi Sarcoma Market: High incidence of HIV/AIDS associated Kaposi sarcoma is o …
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market Analysis & Trends 2024
The global market for Kaposi sarcoma is projected to expand at a modest 2.2% CAGR from 2016 to 2024, with the opportunity in the market rising from US$118.5 mn in 2015 to be worth US$143.2 mn by the end of the forecast period. Hospitals formed the leading distribution channel in 2015, generating over US$40 mn revenue that year. The segment is also slated emerge as the fastest growing segment in…
Synovial Sarcoma - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Synovial Sarcoma - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Pipeline Review, H2 2017, provides an overview of the Synovial Sarcoma (Oncology) pipeline landscape.
Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or…
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market: Patent Expiry of Blockbuster Drugs for Treatment of Kapos …
Kaposi sarcoma is a soft tissue sarcoma that develops in connective tissues, blood vessels, fibrous tissues, and muscles. It is a malignant, multi-centric, neoplastic vascular proliferation, characterized by the development of bluish-red cutaneous nodules on the feet. According to the U.S. Center for Disease Control and Prevention (CDC), Kaposi sarcoma is considered an acquired immune deficiency syndrome (AIDS) defining disease. This report analyzes the current and future prospects of the…
